Actively Recruiting
Michigan Initial Experience Using Tigertriever for Thrombectomy
Led by Henry Ford Health System · Updated on 2026-05-08
150
Participants Needed
1
Research Sites
154 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in the brain) in patients experiencing ischemic stroke within 8 hours of symptom onset.
CONDITIONS
Official Title
Michigan Initial Experience Using Tigertriever for Thrombectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients admitted with large vessel occlusion (LVO) and treated with the Tigertriever as per approved indication
- Tigertriever used as first line treatment in the target vessel
- Signed informed consent
- Age 18 years or older
You will not qualify if you...
- Evidence of acute brain hemorrhage on NCCT or MR at admission
- Prior hemorrhage, stroke, thrombolysis, and/or endovascular therapy in the last 3 months
- Pre-stroke disability with Modified Rankin Scale score of 2 or higher
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Henry Ford Hospital
Detroit, Michigan, United States, 48202
Actively Recruiting
Research Team
A
Alex Chebl, MD
CONTACT
K
Kelly Tundo, RN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here